✦ LIBER ✦

Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer

✍ Scribed by Susan G. Arbuck

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 949 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890315)63:6+<1036::aid-cncr2820631309>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III trial of 5-fluorouracil and

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study

✍ Michael J. O'Connell 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment

Treatment of patients with advanced colo

Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil, and leucovorin

✍ Werner Scheithauer; H. Rosen; R. Schiessel; J. Schüller; M. Karall; F. Ernst; Ch 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Randomized clinical trial of adjuvant ra

Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS)

✍ The AXIS collaborators 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

## Abstract ## Background Postoperative portal vein infusion (PVI) of 5-fluorouracil (5-FU) is a well tolerated and widely applicable treatment for colorectal cancer that might have an enormous public health impact, even if it produced survival benefits of just a few per cent. Very large trials ar

Pre-clinical evaluation of the Gastrimmu

Pre-clinical evaluation of the Gastrimmune immunogen alone and in combination with 5-fluorouracil/leucovorin in a rat colorectal cancer model

✍ Susan A. Watson; Dov Michael; Timothy A. Justin; Stephen Grimes; Teresa M. Morri 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB 👁 2 views

Mature and post-translational precursor gastrin forms are growth factors for colorectal tumours. The immunogen Gastrimmune is composed of the amino terminus of gastrin-17 linked to diphtheria toxoid and raises antibodies in situ which neutralise amidated and glycine-extended gastrin-17. The aim of t

Clinical studies of 5-fluorouracil + pre

Clinical studies of 5-fluorouracil + premarin in the treatment of breast cancer

✍ Taylor, Samuel G. ;Pocock, Stuart J. ;Shnider, Bruce I. ;Colsky, Jacob ;Hall, Th 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

## Abstract Sixty patients with metastatic or primary inoperable breast cancer not suitable for hormone alteration therapy were blindly randomized between weekly 5‐fluorouracil, intravenously, and daily physiologic doses of conjugated estrogens by mouth against weekly 5‐fluorouracil, intravenously,

Treatment of liver metastases from color

Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial

✍ Larsolof Hafström; Boel Engaräs; Stig B Holmberg; Bengt Gustavsson; Per-Ebbe Jön 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 688 KB

Background. Regional therapy for colorectal liver metastases aimed at prolonging survival has not been tested fully in a randomized trial with untreated control subjects. This study explored the efficacy of temporary hepatic artery occlusion followed by intraportal infusion of 5-fluorouracil[5-FU) a